HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Interest Coverage

The Interest Coverage Ratio of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 3, 2026 is 12.40. In the previous year, Interest Coverage Ratio was 2,457.81 — a change of -99.50% (lower).

Interest Coverage

12.40

YoY

-99.50%

Last updated:

Interest Coverage Ratio of HaTay Pharmaceutical JSC is 2024 12.40 . Interest Coverage Ratio of HaTay Pharmaceutical JSC was 2023 2,457.81 . It decreases by -99.50% lower compared to the previous year.

The HaTay Pharmaceutical JSC Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
39.89 VND
Jan 1, 2018
10.66 VND
Jan 1, 2019
17.86 VND
Jan 1, 2020
159.99 VND
Jan 1, 2021
3.33 VND
Jan 1, 2022
8.79 VND
Jan 1, 2023
2,457.81 VND
Jan 1, 2024
12.40 VND
The HaTay Pharmaceutical JSC Interest Coverage history
YEARInterest CoverageYoY
12.40-99.50%
2,457.81+27,861.15%
8.79+163.72%
3.33-97.92%
159.99+796.02%
17.86+67.45%
10.66-73.27%
39.89-68.61%
127.06-87.10%
984.80+7,451.12%
13.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Interest Coverage Ratio of HaTay Pharmaceutical JSC is 12.40 in 2024.

Interest Coverage Ratio of HaTay Pharmaceutical JSC changed from 2,457.81 to 12.40, representing a -99.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — HaTay Pharmaceutical JSC

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — HaTay Pharmaceutical JSC